High-Dose Spinal Cord Stimulation Reduces Long-Term Pain Medication Use in Patients With Failed Back Surgery Syndrome Who Obtained at Least 50% Pain Intensity and Medication Reduction During a Trial Period: A Registry-Based Cohort Study.
Lisa GoudmanAnn De SmedtPatrice ForgetSam S EldabeMaartens MoensPublished in: Neuromodulation : journal of the International Neuromodulation Society (2021)
Registry data on HD-SCS in FBSS patients revealed a statistically significant and sustained decrease in pain medication use, not only on opioids, but also on anti-neuropathic agents in neurostimulation-naïve patients, who positively responded to an SCS trial period with at least 50% pain relief and 50% pain medication decrease, but not in rescue patients.
Keyphrases
- chronic pain
- pain management
- neuropathic pain
- spinal cord
- end stage renal disease
- high dose
- ejection fraction
- newly diagnosed
- healthcare
- peritoneal dialysis
- spinal cord injury
- prognostic factors
- study protocol
- low dose
- machine learning
- coronary artery disease
- phase iii
- acute coronary syndrome
- case report
- patient reported
- open label
- atrial fibrillation
- data analysis
- surgical site infection